Skip to main content
Signal8

Accustem Sciences Inc. (ACUT)

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Accustem Sciences Inc. logo

Accustem Sciences Inc.

OTC:ACUTHealthcare
-9.23%$0.1180
Mkt Cap$1.9M
EV-
Float8.49M
O/S16.07M
VOL610 sh
$ Vol$74
RVOL0.22×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
Accustem Sciences Inc. logoOTC:ACUT$0.1180-9.23%
Historical Data
DateOpenHighLowCloseVolume
Nov 13, 20260.12600.12600.11800.1180610
Nov 12, 20260.13000.13000.13000.13001,581
Nov 11, 20260.13690.13690.13690.1369125
Nov 5, 20260.13000.13000.13000.1300309
Nov 4, 20260.15020.15020.13000.13001,250
Nov 3, 20260.14290.14290.14290.1429630
Oct 29, 20260.13000.13000.13000.1300471
Oct 27, 20260.13600.15000.13600.15005,110
Oct 26, 20260.15500.16000.15490.154916,997
Oct 22, 20260.13360.13360.13360.1336356
Oct 8, 20260.15990.15990.14740.147412,826
Oct 7, 20260.15000.15000.15000.15001,584
Oct 6, 20260.15000.15000.14000.1400284
Oct 5, 20260.13500.13500.13500.13501,070
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
InsiderTypeShares
CERRONE GABRIELE M profile photoCERRONE GABRIELE MPurchase2.0K
CERRONE GABRIELE M profile photoCERRONE GABRIELE MPurchase400
CERRONE GABRIELE M profile photoCERRONE GABRIELE MPurchase9.0K
CERRONE GABRIELE M profile photoCERRONE GABRIELE MPurchase28.2K
CERRONE GABRIELE M profile photoCERRONE GABRIELE MPurchase3.0K
CERRONE GABRIELE M profile photoCERRONE GABRIELE MPurchase35.0K
Shareholders
0.0%
Institutional
(0)
0.0%
Insiderⓘ
(0)
0.0%
5%+ Owners
(0)
100.0%
Unattributed (incl. retail)ⓘ
Unattributed (incl. retail)100.0%
Sources: Form 4O/S: 16.1M · checked 17 Nov 2026 · SEC filings
Insiders & Institutional Holders

Insiders

About

AccuStem Sciences, Inc. operates as a life science firm committed to improving the outlook for individuals battling cancer.

Its primary innovation is the StemPrintER technology, an advanced multi-gene prognostic assay designed to predict the likelihood of recurrence for patients with Endocrine receptor-positive /HER2- breast cancer.

The company also offers Spare, a related diagnostic tool that expands upon StemPrintER by incorporating two additional clinical markers. AccuStem Sciences, Inc. is based in New York, New York.

Key Metrics
Market Cap$1.90M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

SectorHealthcare
IndustryBiotechnology
ExchangeOTC
CountryUSUS
IPO DateMar 3, 2022
Shares Outstanding16.07M
Authorized Shares
Float8.49M
SEC Float (non-affiliate)12.24M
52-Week Range
$0.1170$0.9979
$0.1180(0th percentile)
Volume
Average Daily Volume2.74K
610 today vs 2.74K avg(-78%)

30d Avg

2.74K

60d Avg

2.66K

90d Avg

6.09K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Signal8's dilution snapshot of ACUT as of Jun 30, 2026 records 1 outstanding warrant series, from SEC filings. Accustem Sciences Inc. (OTC: ACUT) traded at $0.1180 on Nov 13, 2026, down 9.23% from the previous close of $0.1300. 52-week range: $0.1170 to $0.9979. The company is in the Healthcare sector (Biotechnology).